Pharma and healthcare packaging specialist Clondalkin Group has invested in new booklet-label manufacturing and finishing equipment at its Glasnevin site.
The site, part of the Group's Specialist Packaging Division, invested in the Prati Vega booklet-label machine to strengthen its offer of exacting compliance and quality performance across multiple study profiles. The increased capacity also enables shorter lead times and greater reliability for its international customer base in the clinical trials sector.
The versatile Vega will provide a range of benefits to Clondalkin's growing customer base. Producing booklets of up to 64 page counts, it features an in-line lamination unit with register control, enabling the application of Braille in register to the outer laminate.The Vega also incorporates a hotmelt coating unit and Pharma Code scanning.
Clondalkin also installed two complete finishing lines from Prati, fully equipped with inline inkjet coding and full vision inspection, bringing the site's total number of inspection units to four.
Barry Marron, site director at Glasnevin, says: "Each booklet-label we manufacture for our clinical trial customers will undergo up to 15 separate checks as part of our uncompromising quality and processes. Our site is extensively equipped in all stages of the print and production processes from origination and print through to conversion and delivery, and this investment represents our continued commitment to improve our processes, expand our capabilities and increase our flexibility ."
